IRMD - IRadimed Corporation
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories.
As of May 15, 2026: spot at $86.40, ATM IV 41.5%, max pain $94.50, net GEX -$15.2K.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Market Cap
- $1.09B
- P/E Ratio
- 46.17
- Beta
- 0.91
- 52-Week Range
- 50.88-107.9
- Dividend Yield
- $1.21
- CEO
- Roger E. Susi
- Employees
- 160
- IPO Date
- Jul 16, 2014
- Exchange
- NASDAQ
What IRMD Looks Like to Options Traders Today
IV rank of 5.0% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); negative net gamma exposure (-$15.2K) means dealers hedge with trend, amplifying realized volatility and accelerating directional moves; the 25-delta skew (0.124) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The IRMD overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked IRMD overview questions
- What is IRMD?
- IRMD is the ticker symbol for IRadimed Corporation, a listed security. IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. Listed on NASDAQ. IRMD is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the IRMD options snapshot look like today?
- As of May 15, 2026, the IRMD options snapshot shows spot at $86.40, ATM IV 41.5%, IV rank 5.0%, max pain $94.50, net GEX -$15.2K, expected move 11.90%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are IRMD's key statistics?
- IRadimed Corporation (IRMD) carries a market capitalization of $1.09B, trailing P/E ratio of 46.17, beta of 0.91 relative to the broader market, 52-week range of 50.88-107.9. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does IRMD belong to?
- IRadimed Corporation operates in the Healthcare sector, in the Medical - Devices industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare IRMD's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the IRMD data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).